Seek Returns logo

IQV vs. RVTY: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at IQV and RVTY, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolIQVRVTY
Company NameIQVIA Holdings Inc.Revvity, Inc.
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
Market Capitalization32.65 billion USD10.64 billion USD
ExchangeNYSENYSE
Listing DateMay 9, 2013February 21, 1973
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of IQV and RVTY by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

IQV vs. RVTY: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolIQVRVTY
5-Day Price Return1.39%2.52%
13-Week Price Return33.79%-2.76%
26-Week Price Return-2.05%-18.76%
52-Week Price Return-21.01%-23.74%
Month-to-Date Return3.33%4.32%
Year-to-Date Return-2.27%-17.84%
10-Day Avg. Volume1.14M1.11M
3-Month Avg. Volume2.21M1.31M
3-Month Volatility45.60%36.53%
Beta1.340.99

Profitability

Return on Equity (TTM)

IQV

19.96%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

In the upper quartile for the Life Sciences Tools & Services industry, IQV’s Return on Equity of 19.96% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

RVTY

3.71%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

RVTY’s Return on Equity of 3.71% is in the lower quartile for the Life Sciences Tools & Services industry. This indicates a less efficient generation of profit from its equity base when compared to its competitors.

IQV vs. RVTY: A comparison of their Return on Equity (TTM) against the Life Sciences Tools & Services industry benchmark.

Net Profit Margin (TTM)

IQV

7.88%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

IQV’s Net Profit Margin of 7.88% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

RVTY

10.19%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

RVTY’s Net Profit Margin of 10.19% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

IQV vs. RVTY: A comparison of their Net Profit Margin (TTM) against the Life Sciences Tools & Services industry benchmark.

Operating Profit Margin (TTM)

IQV

13.85%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

IQV’s Operating Profit Margin of 13.85% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

RVTY

13.57%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

RVTY’s Operating Profit Margin of 13.57% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

IQV vs. RVTY: A comparison of their Operating Profit Margin (TTM) against the Life Sciences Tools & Services industry benchmark.

Profitability at a Glance

SymbolIQVRVTY
Return on Equity (TTM)19.96%3.71%
Return on Assets (TTM)4.50%2.29%
Net Profit Margin (TTM)7.88%10.19%
Operating Profit Margin (TTM)13.85%13.57%
Gross Profit Margin (TTM)34.25%55.93%

Financial Strength

Current Ratio (MRQ)

IQV

0.84

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

IQV’s Current Ratio of 0.84 falls into the lower quartile for the Life Sciences Tools & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

RVTY

3.33

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

RVTY’s Current Ratio of 3.33 is in the upper quartile for the Life Sciences Tools & Services industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.

IQV vs. RVTY: A comparison of their Current Ratio (MRQ) against the Life Sciences Tools & Services industry benchmark.

Debt-to-Equity Ratio (MRQ)

IQV

2.68

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

With a Debt-to-Equity Ratio of 2.68, IQV operates with exceptionally high leverage compared to the Life Sciences Tools & Services industry norm. This suggests an aggressive reliance on debt financing, which can magnify returns but also significantly elevates financial risk.

RVTY

0.43

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

RVTY’s Debt-to-Equity Ratio of 0.43 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

IQV vs. RVTY: A comparison of their Debt-to-Equity Ratio (MRQ) against the Life Sciences Tools & Services industry benchmark.

Interest Coverage Ratio (TTM)

IQV

3.68

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

IQV’s Interest Coverage Ratio of 3.68 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.

RVTY

15.30

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

RVTY’s Interest Coverage Ratio of 15.30 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.

IQV vs. RVTY: A comparison of their Interest Coverage Ratio (TTM) against the Life Sciences Tools & Services industry benchmark.

Financial Strength at a Glance

SymbolIQVRVTY
Current Ratio (MRQ)0.843.33
Quick Ratio (MRQ)0.812.75
Debt-to-Equity Ratio (MRQ)2.680.43
Interest Coverage Ratio (TTM)3.6815.30

Growth

Revenue Growth

IQV vs. RVTY: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

IQV vs. RVTY: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

IQV

0.00%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

IQV currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

RVTY

0.32%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

RVTY’s Dividend Yield of 0.32% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.

IQV vs. RVTY: A comparison of their Dividend Yield (TTM) against the Life Sciences Tools & Services industry benchmark.

Dividend Payout Ratio (TTM)

IQV

0.00%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

IQV has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

RVTY

11.88%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

RVTY’s Dividend Payout Ratio of 11.88% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

IQV vs. RVTY: A comparison of their Dividend Payout Ratio (TTM) against the Life Sciences Tools & Services industry benchmark.

Dividend at a Glance

SymbolIQVRVTY
Dividend Yield (TTM)0.00%0.32%
Dividend Payout Ratio (TTM)0.00%11.88%

Valuation

Price-to-Earnings Ratio (TTM)

IQV

26.37

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

In the lower quartile for the Life Sciences Tools & Services industry, IQV’s P/E Ratio of 26.37 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

RVTY

37.17

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

RVTY’s P/E Ratio of 37.17 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

IQV vs. RVTY: A comparison of their Price-to-Earnings Ratio (TTM) against the Life Sciences Tools & Services industry benchmark.

Price-to-Sales Ratio (TTM)

IQV

2.08

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

In the lower quartile for the Life Sciences Tools & Services industry, IQV’s P/S Ratio of 2.08 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

RVTY

3.79

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

RVTY’s P/S Ratio of 3.79 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

IQV vs. RVTY: A comparison of their Price-to-Sales Ratio (TTM) against the Life Sciences Tools & Services industry benchmark.

Price-to-Book Ratio (MRQ)

IQV

4.72

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

IQV’s P/B Ratio of 4.72 is in the upper tier for the Life Sciences Tools & Services industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

RVTY

1.51

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

RVTY’s P/B Ratio of 1.51 is in the lower quartile for the Life Sciences Tools & Services industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

IQV vs. RVTY: A comparison of their Price-to-Book Ratio (MRQ) against the Life Sciences Tools & Services industry benchmark.

Valuation at a Glance

SymbolIQVRVTY
Price-to-Earnings Ratio (TTM)26.3737.17
Price-to-Sales Ratio (TTM)2.083.79
Price-to-Book Ratio (MRQ)4.721.51
Price-to-Free Cash Flow Ratio (TTM)16.2321.07